Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
4.100
+0.090 (2.24%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Bicycle Therapeutics Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Bicycle Therapeutics stock have an average target of 13.57, with a low estimate of 5.00 and a high estimate of 36. The average target predicts an increase of 230.98% from the current stock price of 4.10.
Analyst Consensus: Buy
* Price targets were last updated on May 22, 2026.
Analyst Ratings
The average analyst rating for Bicycle Therapeutics stock from 10 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 5 | 5 | 5 | 5 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 4 | 4 | 4 | 4 | 4 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 11 | 11 | 11 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Buy Maintains $15 | Buy | Maintains | $15 | +265.85% | May 22, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $12 | Hold | Maintains | $12 | +192.68% | May 18, 2026 |
| Truist Financial | Truist Financial | Hold Maintains $8 → $7 | Hold | Maintains | $8 → $7 | +70.73% | May 1, 2026 |
| Jefferies | Jefferies | Buy Maintains $13 → $12 | Buy | Maintains | $13 → $12 | +192.68% | Apr 30, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Apr 30, 2026 |
Financial Forecast
Revenue This Year
18.24M
from 72.59M
Decreased by -74.88%
Revenue Next Year
14.11M
from 18.24M
Decreased by -22.61%
EPS This Year
-2.28
from -3.16
EPS Next Year
-2.13
from -2.28
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 40.0M | 72.0M | |
| Avg | 18.2M | 14.1M | |
| Low | 3.1M | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -44.9% | 294.8% | |
| Avg | -74.9% | -22.6% | |
| Low | -95.7% | -100.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -1.30 | -1.32 | |
| Avg | -2.28 | -2.13 | |
| Low | -2.86 | -2.56 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.